9th International Course on Drug Resistant Epilepsies

back

ILAE Curriculum Learning Objectives addressed by this course

• 1.1.1 Describe the major etiologies for epilepsy (i.e. structural, genetic, infectious, metabolic, immune, and neurodegenerative) (L1)
• 1.1.2 Describe the common structural etiologies
• 1.1.3 Describe the common genetic causes of epilepsy
• 1.1.5 Describe the common metabolic causes of epilepsy
• 1.2.1 Decide on which patients to do genetic testing (L2)
• 1.2.3 Interpret and apply the results of genetic testing accurately in the clinical context (L3)
• 1.3.1 Learn and recognize the seizure semiology and distinguish it from other non-epileptic manifestations
• 1.3.2 Extract semiology information from patient history
• 1.3.3 Extract semiology information from video recordings
• 1.3.4 Interpret semiological signs and symptoms allowing hypotheses on the localization of focal seizures
• 1.3.5 Interpret semiological signs and symptoms suggesting focal vs. generalized onset
• 1.3.6 Classify seizures according to the ILAE classification
• 1.4.10 Recognize and describe ictal patterns (L2)
• 1.4.11 Recognize and describe ictal and interictal patterns with intracranial recordings (L3)
• 1.6.1 Decide which patients should receive lab tests and which types of tests should be ordered (L1)
• 1.7.2 Correctly distinguish between focal and generalized epilepsies and recognize epileptic encephalopathies (L1)
• 1.7.3 Correctly diagnose and classify focal epilepsies (L2)
• 1.7.4 Correctly diagnose and classify generalized epilepsies (L1)
• 1.8.2 Recognize the semiology of PNES and the use of video-EEG procedures and suggestion techniques in the diagnosis of suspected PNES (L2)
• 3.1.1 Identify the spectrum of action for antiepileptic drugs (L1)
• 3.1.2 Demonstrate knowledge of pharmacokinetics and pharmacodynamics (L1)
• 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
• 3.1.4 Demonstrate knowledge of appropriate monitoring of AES serum levels (L2)
• 3.1.5 Demonstrate knowledge about drug interactions (e.g. enzyme induction, etc.) for AED/AED and AED/concomitant medication
• 3.2.1 Recommend appropriate therapy according to seizure type (L1)
• 3.2.2 Recommend appropriate therapy according to epilepsy syndrome (L2)
• 3.5.1 Identify patients who are drug resistant according to the current ILAE definition (L1)
• 4.1.1 Demonstrate working knowledge of indications for pre-surgical evaluation (L1)
• 4.2.1 Describe the importance of early surgical intervention regarding neuro-developmental, cognitive, behavioral and social integration aspects (L2)
• 4.3.1 Recommend and interpret video-EEG monitoring as appropriate) (L3)
• 4.4.1 Demonstrate working knowledge of etiologies amenable to surgical treatment and their prognoses in all age groups (L2)
• 6.1.1 Recognize psychiatric comorbidities, such as depression, anxiety, attention deficit and hyperactivity disorder, psychosis and autism spectrum disorders (L2)
• 7.2.1 Demonstrate working knowledge of epileptogenesis (L3)